title: Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
authors.affiliation: University of Pittsburgh Medical Center, Thomas E. Starzl Transplantation Institute, PA, USA.
authors.forename: R
authors.initials: R
authors.lastname: Shapiro
authors.forename: V P
authors.initials: VP
authors.lastname: Scantlebury
authors.forename: M L
authors.initials: ML
authors.lastname: Jordan
authors.forename: C
authors.initials: C
authors.lastname: Vivas
authors.forename: H A
authors.initials: HA
authors.lastname: Gritsch
authors.forename: J
authors.initials: J
authors.lastname: McCauley
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: T R
authors.initials: TR
authors.lastname: Hakala
authors.forename: R L
authors.initials: RL
authors.lastname: Simmons
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D003920:Diabetes Mellitus / Q000139:chemically induced*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation; D008875:Middle Aged; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus